Journal of critical care
-
Journal of critical care · Dec 2020
The characteristics and outcomes of 681 severe cases with COVID-19 in China.
To clarify the epidemiological, clinical, and therapeutic features of patients with severe COVID-19. ⋯ The combination of NLR and acute myocardial injury on admission was highly predictive of mortality and survival. Clinicians should adopt more aggressive strategies for patients with a high NLR (>6.66) combined with myocardial injury. β-blockers and ACEI/ARB, as well as arbidol and ribavirin, were effective in COVID-19 patients with cardiovascular disease.
-
Journal of critical care · Dec 2020
Diarrhea and elevation of plasma markers of cholestasis are common and often occur concomitantly in critically ill patients.
We aimed to describe epidemiology of diarrhea and cholestasis in critically ill patients and explore associations between these two conditions. ⋯ Cholestasis is more common in patients with diarrhea and vice versa. Diarrhea and cholestasis both occur in approximately one quarter of ICU patients, with significant proportion manifesting beyond the first week in the ICU.
-
Journal of critical care · Dec 2020
Case ReportsSevere arterial thromboembolism in patients with Covid-19.
The novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has emerged early December 2019 and was recently confirmed by the World Health Organization (WHO) to be a public health emergency of international concern. Earlier reports have shown coagulopathy in patients with severe coronavirus disease 2019 (Covid-19). ⋯ This case series suggest that even in absence of overt DIC, arterial thromboembolic complications occur in critically ill patients with Covid-19. Further studies are needed to determine which parameters are useful in monitoring coagulopathy and which dose of anti-thrombotic therapy in Covid-19 patients is adequate, even when overt DIC is not present.